Clinical Study ION-ZCM1 Topical Treatment - Infection - Diabetic Foot

Clinical Study ION-ZCM1 Topical Treatment - Infection - Diabetic Foot

Case Summary Topical Application:
  1. IBAL based ZCM1 @ 10% in a lotion-based carrier.
  2. Period of Treatment: 60 Days only using the cream compound – September 15 thru November 15, 2023.
  3. Application Area: Visual area of infections and slightly beyond covering red areas. 
  4. Amputation was indicated because conventional treatment had failed.
  5. Application Method: Daily, 2 times per day, using 1.0 to 2.0 ml for each application.
  6. Total Amount Applied Through Treatment Period: 200 ml Diagnosis: Chronic Infection, Potential Leg / Foot amputation.
  7. Post Treatment Exam: BW Patient – Photos. Outcome: Pathology - No evidence of Infection, Limited Scarring, No Surgery, Extensive financial savings over planned Standard of Care Protocol.
Full Study with Photos Attached

    • Related Articles

    • Access Portal for Health Providers: 2+ Cations Support System

      The 2+ Cations Support Portal is exclusively designed for Health Providers. It offers a comprehensive suite of resources, including training modules, promotional content, and research findings on IBAL-based products. These are intended for the ...